Alimera Sciences (ALIM) Misses Q2 EPS by 3c

Alimera Sciences (NASDAQ: ALIM) reported Q2 EPS of ($0.25), $0.03 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $5.8 million versus the consensus estimate of $6.49 million.

For earnings history and earnings-related data on Alimera Sciences (ALIM) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Movano (MOVE) Misses Q2 EPS by 195c